Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02181426 · ClinicalTrials.gov registry record · NA

Dose Response of Ketorolac in Knee Arthroscopy

A NA study, sponsored by Medical University of South Carolina.

Completed
Registry status
NA
Development phase
112
Enrollment target

NCT02181426: Completed NA study, sponsored by Medical University of South Carolina.

NCT02181426 is a NA study that has completed, run by Medical University of South Carolina. The registered enrollment target is 112 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02181426, a NA study, has completed, sponsored by Medical University of South Carolina.

COMPLETED
Registry status
NA
Development phase
112 participants
Enrollment target

Study Summary

Ketorolac is administered as current practice to the majority of patients undergoing knee arthroscopy, the appropriate dose of ketorolac to be administered has not been evaluated.

Primary Outcome

Total PACU opioid consumption measured in intravenous morphine mg equivalents (IV MME).

Interventions

  • DRUG Ketorolac Dose

Trial Details

FieldValue
Enrollment Target 112 participants
Start Date 2012-03
Est. Completion 2016-12-15
Phase NA

What the finished NCT02181426 record still lists

NCT02181426 is an interventional study that assigns participants to a tested intervention. The registered 112 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).

The record links to 0 conditions, and to 1 intervention - of which Ketorolac Dose is the first listed.

NCT02181426 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02181426 about?

NCT02181426 is a clinical study titled "Dose Response of Ketorolac in Knee Arthroscopy". Ketorolac is administered as current practice to the majority of patients undergoing knee arthroscopy, the appropriate dose of ketorolac to be administered has not been evaluated.

What is the current status of trial NCT02181426?

This trial is currently completed. It is a NA study. The enrollment target is 112 participants. The study started on 2012-03. Estimated completion is 2016-12-15.

What interventions are being tested in trial NCT02181426?

The interventions under investigation include: Ketorolac Dose (DRUG).

Who is sponsoring clinical trial NCT02181426?

This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02181426's enrollment target sits among peer trials

112 813th of 2000 higher than 1,185 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04511013 · 112 participants · Phase 2

    A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

  • NCT04551560 · 112 participants · NA

    Stress and Congestive Heart Failure

  • NCT04872166 · 112 participants · Phase 1

    A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer

  • NCT05024773 · 112 participants · Phase 3

    Study of ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02181426, the US trial registry maintained by the National Library of Medicine. NCT02181426 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.